150 related articles for article (PubMed ID: 33501810)
21. Altered oral microbiota in chronic hepatitis B patients with different tongue coatings.
Zhao Y; Mao YF; Tang YS; Ni MZ; Liu QH; Wang Y; Feng Q; Peng JH; Hu YY
World J Gastroenterol; 2018 Aug; 24(30):3448-3461. PubMed ID: 30122883
[TBL] [Abstract][Full Text] [Related]
22. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
[TBL] [Abstract][Full Text] [Related]
23. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
[TBL] [Abstract][Full Text] [Related]
24. Distinct Bile Acid Profiles in Patients With Chronic Hepatitis B Virus Infection Reveal Metabolic Interplay Between Host, Virus and Gut Microbiome.
Sun Z; Huang C; Shi Y; Wang R; Fan J; Yu Y; Zhang Z; Zhu K; Li M; Ni Q; Chen Z; Zheng M; Yang Z
Front Med (Lausanne); 2021; 8():708495. PubMed ID: 34671614
[TBL] [Abstract][Full Text] [Related]
25. Gut Microbiota and Liver Injury (II): Chronic Liver Injury.
Baker SS; Baker RD
Adv Exp Med Biol; 2020; 1238():39-54. PubMed ID: 32323179
[TBL] [Abstract][Full Text] [Related]
26. Gut Dysbiosis Associated With Hepatitis C Virus Infection.
Inoue T; Nakayama J; Moriya K; Kawaratani H; Momoda R; Ito K; Iio E; Nojiri S; Fujiwara K; Yoneda M; Yoshiji H; Tanaka Y
Clin Infect Dis; 2018 Aug; 67(6):869-877. PubMed ID: 29718124
[TBL] [Abstract][Full Text] [Related]
27. Dynamic Differences Of Red Cell Distribution Width Levels Contribute To The Differential Diagnosis Of Hepatitis B Virus-related Chronic Liver Diseases: A Case-control Study.
Zhu M; Han M; Xiao X; Lu S; Guan Z; Song Y; Liu C
Int J Med Sci; 2019; 16(5):720-728. PubMed ID: 31217740
[No Abstract] [Full Text] [Related]
28. Characteristics of gut microbiota in patients with metabolic associated fatty liver disease.
Yang C; Xu J; Xu X; Xu W; Tong B; Wang S; Ji R; Tan Y; Zhu Y
Sci Rep; 2023 Jun; 13(1):9988. PubMed ID: 37340081
[TBL] [Abstract][Full Text] [Related]
29. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
[TBL] [Abstract][Full Text] [Related]
30. [Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity].
Zhu F; Ning Q; Chen Y; Tao XX; Yan WM; Xi D; Yan FM; Hao LJ; Luo XP
Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):385-8. PubMed ID: 15268797
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of the risk factors of hepatocellular carcinoma in cirrhotic patients with chronic hepatitis B].
Zhang Y; Peng L; Cao Y; Zeng Z; Wu Y; Shi H; Chen S; Guo J
Zhonghua Gan Zang Bing Za Zhi; 2015 Jul; 23(7):512-6. PubMed ID: 26398842
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of lamivudine on hepatitis B viral status and liver function in patients with hepatitis B virus-related hepatocellular carcinoma.
Kim JH; Park JW; Koh DW; Lee WJ; Kim CM
Liver Int; 2009 Feb; 29(2):203-7. PubMed ID: 18662281
[TBL] [Abstract][Full Text] [Related]
33. Progression to cirrhosis, hepatocellular carcinoma and liver-related mortality in chronic hepatitis B patients in Italy.
Ieluzzi D; Covolo L; Donato F; Fattovich G
Dig Liver Dis; 2014 May; 46(5):427-32. PubMed ID: 24548819
[TBL] [Abstract][Full Text] [Related]
34. Advances in Gut Microbiota of Viral Hepatitis Cirrhosis.
Wang Y; Pan CQ; Xing H
Biomed Res Int; 2019; 2019():9726786. PubMed ID: 31886272
[TBL] [Abstract][Full Text] [Related]
35. The dysregulation of endoplasmic reticulum stress response in acute-on-chronic liver failure patients caused by acute exacerbation of chronic hepatitis B.
Ren F; Shi H; Zhang L; Zhang X; Wen T; Xie B; Zheng S; Chen Y; Li L; Chen D; Duan Z
J Viral Hepat; 2016 Jan; 23(1):23-31. PubMed ID: 26234401
[TBL] [Abstract][Full Text] [Related]
36. Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy.
Kang Y; Cai Y
J Hosp Infect; 2017 Aug; 96(4):342-348. PubMed ID: 28545829
[TBL] [Abstract][Full Text] [Related]
37. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
Hu HH; Liu J; Lin YL; Luo WS; Chu YJ; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; You SL; Yang HI; Chen CJ;
Gut; 2016 Sep; 65(9):1514-21. PubMed ID: 26642861
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of the relationship between hepatitis B virus precore and basal core promoter mutations and acute-on-chronic liver failure].
Ma XY; Han T; Pei YZ; Zhao ZG; Gao YT; Li Y; Jing L
Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):644-8. PubMed ID: 23207226
[TBL] [Abstract][Full Text] [Related]
39. Improvement of gut microbiome and intestinal permeability following splenectomy plus pericardial devascularization in hepatitis B virus-related cirrhotic portal hypertension.
Zhao Y; Zhou R; Guo Y; Chen X; Zhang A; Wang J; Ji F; Qin B; Geng J; Kong G; Li Z
Front Immunol; 2022; 13():941830. PubMed ID: 36159870
[TBL] [Abstract][Full Text] [Related]
40. Soluble programmed death-1 is a useful indicator for inflammatory and fibrosis severity in chronic hepatitis B.
Zhou L; Li X; Huang X; Chen L; Gu L; Huang Y
J Viral Hepat; 2019 Jul; 26(7):795-802. PubMed ID: 30578715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
